vs
GEO GROUP INC（GEO）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是GEO GROUP INC的1.1倍（$772.1M vs $708.4M），Revvity净利率更高（12.7% vs 4.5%，领先8.3%），GEO GROUP INC同比增速更快（16.6% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-153.6M），过去两年Revvity的营收复合增速更高（9.0% vs 8.1%）
GEO集团是一家总部位于美国佛罗里达州博卡拉顿的上市企业，核心业务为投资及运营私营监狱、心理健康相关机构，业务覆盖美国、澳大利亚、南非、英国等市场，运营设施包含移民拘留中心、低安保级别拘留中心、心理健康及 residential 治疗机构，同时也承接政府所有设施的委托管理服务。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GEO vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.1倍
$708.4M
营收增速更快
GEO
高出10.7%
5.9%
净利率更高
RVTY
高出8.3%
4.5%
自由现金流更多
RVTY
多$315.4M
$-153.6M
两年增速更快
RVTY
近两年复合增速
8.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $708.4M | $772.1M |
| 净利润 | $31.8M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 11.8% | 14.5% |
| 净利率 | 4.5% | 12.7% |
| 营收同比 | 16.6% | 5.9% |
| 净利润同比 | 105.1% | 3.9% |
| 每股收益（稀释后） | $0.16 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEORVTY
| Q4 25 | $708.4M | $772.1M | ||
| Q3 25 | $682.3M | $698.9M | ||
| Q2 25 | $636.2M | $720.3M | ||
| Q1 25 | $604.6M | $664.8M | ||
| Q4 24 | $607.7M | $729.4M | ||
| Q3 24 | $603.1M | $684.0M | ||
| Q2 24 | $607.2M | $691.7M | ||
| Q1 24 | $605.7M | $649.9M |
净利润GEORVTY
| Q4 25 | $31.8M | $98.4M | ||
| Q3 25 | $173.9M | $46.7M | ||
| Q2 25 | $29.1M | $53.9M | ||
| Q1 25 | $19.6M | $42.2M | ||
| Q4 24 | $15.5M | $94.6M | ||
| Q3 24 | $26.3M | $94.4M | ||
| Q2 24 | $-32.5M | $55.4M | ||
| Q1 24 | $22.7M | $26.0M |
毛利率GEORVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率GEORVTY
| Q4 25 | 11.8% | 14.5% | ||
| Q3 25 | 6.0% | 11.7% | ||
| Q2 25 | 11.3% | 12.6% | ||
| Q1 25 | 10.1% | 10.9% | ||
| Q4 24 | 11.2% | 16.3% | ||
| Q3 24 | 13.7% | 14.3% | ||
| Q2 24 | 13.2% | 12.4% | ||
| Q1 24 | 13.1% | 6.8% |
净利率GEORVTY
| Q4 25 | 4.5% | 12.7% | ||
| Q3 25 | 25.5% | 6.7% | ||
| Q2 25 | 4.6% | 7.5% | ||
| Q1 25 | 3.2% | 6.4% | ||
| Q4 24 | 2.5% | 13.0% | ||
| Q3 24 | 4.4% | 13.8% | ||
| Q2 24 | -5.4% | 8.0% | ||
| Q1 24 | 3.7% | 4.0% |
每股收益（稀释后）GEORVTY
| Q4 25 | $0.16 | $0.86 | ||
| Q3 25 | $1.24 | $0.40 | ||
| Q2 25 | $0.21 | $0.46 | ||
| Q1 25 | $0.21 | $0.35 | ||
| Q4 24 | $0.14 | $0.77 | ||
| Q3 24 | $0.19 | $0.77 | ||
| Q2 24 | $-0.25 | $0.45 | ||
| Q1 24 | $0.14 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.0M | $919.9M |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $1.5B | $7.3B |
| 总资产 | $3.8B | $12.2B |
| 负债/权益比越低杠杆越低 | 1.11× | — |
8季度趋势，按日历期对齐
现金及短期投资GEORVTY
| Q4 25 | $69.0M | $919.9M | ||
| Q3 25 | $183.9M | $931.4M | ||
| Q2 25 | $67.9M | $991.8M | ||
| Q1 25 | $64.8M | $1.1B | ||
| Q4 24 | $76.9M | $1.2B | ||
| Q3 24 | $70.6M | $1.2B | ||
| Q2 24 | $46.3M | $2.0B | ||
| Q1 24 | $126.5M | $1.7B |
总债务GEORVTY
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GEORVTY
| Q4 25 | $1.5B | $7.3B | ||
| Q3 25 | $1.5B | $7.4B | ||
| Q2 25 | $1.4B | $7.6B | ||
| Q1 25 | $1.3B | $7.6B | ||
| Q4 24 | $1.3B | $7.7B | ||
| Q3 24 | $1.3B | $7.9B | ||
| Q2 24 | $1.3B | $7.9B | ||
| Q1 24 | $1.3B | $7.8B |
总资产GEORVTY
| Q4 25 | $3.8B | $12.2B | ||
| Q3 25 | $3.8B | $12.1B | ||
| Q2 25 | $3.7B | $12.4B | ||
| Q1 25 | $3.6B | $12.4B | ||
| Q4 24 | $3.6B | $12.4B | ||
| Q3 24 | $3.6B | $12.8B | ||
| Q2 24 | $3.6B | $13.4B | ||
| Q1 24 | $3.7B | $13.4B |
负债/权益比GEORVTY
| Q4 25 | 1.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-117.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-153.6M | $161.8M |
| 自由现金流率自由现金流/营收 | -21.7% | 21.0% |
| 资本支出强度资本支出/营收 | 5.1% | 2.6% |
| 现金转化率经营现金流/净利润 | -3.69× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $-124.9M | $509.4M |
8季度趋势，按日历期对齐
经营现金流GEORVTY
| Q4 25 | $-117.3M | $182.0M | ||
| Q3 25 | $79.6M | $138.5M | ||
| Q2 25 | $39.2M | $134.3M | ||
| Q1 25 | $71.2M | $128.2M | ||
| Q4 24 | $18.5M | $174.2M | ||
| Q3 24 | $109.3M | $147.9M | ||
| Q2 24 | $31.2M | $158.6M | ||
| Q1 24 | $83.3M | $147.6M |
自由现金流GEORVTY
| Q4 25 | $-153.6M | $161.8M | ||
| Q3 25 | $-14.1M | $120.0M | ||
| Q2 25 | $2.4M | $115.5M | ||
| Q1 25 | $40.5M | $112.2M | ||
| Q4 24 | $-2.3M | $149.8M | ||
| Q3 24 | $90.5M | $125.6M | ||
| Q2 24 | $6.8M | $136.6M | ||
| Q1 24 | $68.5M | $129.7M |
自由现金流率GEORVTY
| Q4 25 | -21.7% | 21.0% | ||
| Q3 25 | -2.1% | 17.2% | ||
| Q2 25 | 0.4% | 16.0% | ||
| Q1 25 | 6.7% | 16.9% | ||
| Q4 24 | -0.4% | 20.5% | ||
| Q3 24 | 15.0% | 18.4% | ||
| Q2 24 | 1.1% | 19.7% | ||
| Q1 24 | 11.3% | 20.0% |
资本支出强度GEORVTY
| Q4 25 | 5.1% | 2.6% | ||
| Q3 25 | 13.7% | 2.6% | ||
| Q2 25 | 5.8% | 2.6% | ||
| Q1 25 | 5.1% | 2.4% | ||
| Q4 24 | 3.4% | 3.4% | ||
| Q3 24 | 3.1% | 3.3% | ||
| Q2 24 | 4.0% | 3.2% | ||
| Q1 24 | 2.4% | 2.7% |
现金转化率GEORVTY
| Q4 25 | -3.69× | 1.85× | ||
| Q3 25 | 0.46× | 2.97× | ||
| Q2 25 | 1.35× | 2.49× | ||
| Q1 25 | 3.64× | 3.03× | ||
| Q4 24 | 1.19× | 1.84× | ||
| Q3 24 | 4.15× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 3.67× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEO
| Us Corrections And Detention | $498.0M | 70% |
| Electronic Monitoring And Supervision Services | $83.7M | 12% |
| Reentry Services | $72.2M | 10% |
| AU | $49.1M | 7% |
| ZA | $5.4M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
